Shareholder Value and Financial Outlook

STRONG 2022 PERFORMANCE FULL YEAR 2022 ADJUSTED EPS OF $23.27 with year over year growth of 14%, above our 10%-13% long-term average adjusted EPS target 817 • STRONG GROWTH IN EVERNORTH AND CIGNA HEALTHCARE 2022 Evernorth revenue growth of 6% and adjusted earnings growth of 5%, in-line with updated long-term average target range of 5%-7% 2022 Cigna Healthcare adjusted earnings growth of 13%, above long-term average target range of 8%-10% with year over year margin expansion driven by an improved MCR Returned $9B TO SHAREHOLDERS through share repurchase and an attractive dividend Confidential, unpublished property of Cigna. 2023 Cigna

View entire presentation